SUMMARY One fifth of all cases of A virus hepatitis (AVH) have symptoms of gastroenteritis at the onset. This study investigated the mediated intestinal absorption of D-xylose (D-xyl) and 3-o-methyl-D-glucose (3-omG) and the non-mediated permeation of lactulose (Lacl, mol wt 342) and L-rhamnose (L-rh, mol wt 164) during acute and remission phases of AVH. Ten patients with AVH were given an oral load containing these sugars (5 g D-xyl: 2*5 g 3-omG, 1 g L-rh, 5 g lacl in 250 ml water) once during the acute phase and again during remission. The same load was given once to a group of 22 healthy controls. The mean concentration of D-xyl in urine and the ratio of D-xyl to 3-omG in plasma and urine were normal in both the AVH phases, ruling out intestinal malabsorption even in the acute phase. This study showed a significant increase in non-mediated permeation to Lacl, but not to L-rh, during the acute phase. These data indicate that the barrier function of the intestine is compromised in AVH infection while the absorptive function is not. An abnormally low concentration of D-xyl and 3-omG in plasma at one hour was found in all patients during the acute phase. This finding cannot be explained by alterations in intestinal absorption, but could be accounted for by increased space distribution of the sugars because of increased diffusion into tissue cells and/or expansion of the extracellular space by fluid retention.
A-virus hepatitis (AVH) is
interference by variables such as distribution space, gastric emptying, and renal clearance. One of these modifications is the determination of the D-xylose (D-xyl) plasma concentration peak at one hour (3-omG) which is completely excreted in the urine unmetabolised7 and whose absorption is much less hindered by intestinal disease than is that of D-xyl. 7 This modification allows the correction of plasma and/or urine xylose concentrations by calculating the ratio of D-xyl to 3-omG (Menzies' method).9
Because little is known about intestinal dysfunction during viral hepatitis, we designed a sugar absorption study using these new procedures, in patients with AVH.
The measurement of passive intestinal permeability has been recognised recently as a more sensitive tool to explore the functional integrity of the gut. L13 To include this new evaluation we have used a multiple sugar oral load94 consisting of D-xyl, 3 -omG, lactulose (Lacd) and L-rhamnose (L-rh).
This test allows simultaneous evaluation of mediated absorption (D-xyl and 3-omG), and non-mediated permeation to small molecules (L-rh, mol wt 164), which are passively absorbed through cell aqueous pores'`as well as to disaccharide molecules (Lacl, mol wt 342), whose permeation is thought to be through larger channels related to the tight junctions and/or cell extrusion zones. 15 An increase in non-mediated intestinal permeation to lactulose was recognised in the acute phase of AVH, while the mediated absorption appeared to be unaffected. Results Table 1 shows biochemical data of the hepatitis patients. All were icteric at the onset of the disease; bilirubin and transaminase values had returned to control levels at the end of the thirty day study period. Renal function was normal in patients and controls, as proven by creatininaemia and urine data. All patients were untreated throughout the observation period. Figure 1 shows the mean plasma levels of D-xyl and 3-omG at different times after oral load. Figure 2 reports plasma concentrations of D-xyl and 3-omG at one hour in each patient and control. The concentrations of both sugars were lower than normal in the acute phase of hepatitis and had returned to normal 30 days later. Table 2 shows the mean one hour xylosaemia corrected according to Haeney, the mean plasma concentration/time area (PCTA) of D-xyl and 3-omG, and the mean plasma ratio of D-xyl to 3-omG. Only the D-xyl/3-omG ratio shows no significant variation among acute and remission phases of AVH and controls. Table 3 shows per cent recovery of the different sugars in urine, and the D-xyl/3-omG and Lacl/L-rh ratios. The excretion of D-xyl and 3-omG was similar in patients during both AVH phases and in controls 
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